Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, indirubin-3′-monoxime

AIDS Research and Human Retroviruses

Volumn 28, Issue 2, 2012, Pages 182-187

  Toossi, Zahra ^a,b   Wu, Mianda ^a   Hirsch, Christina S ^a   Mayanja Kizza, Harriet ^c,d   Baseke, Joy ^d   Aung, Htin ^a   Canaday, David H ^a   Fujinaga, Koh ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

INDIRUBIN; INDIRUBIN 3' MONOXIME; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION TUBERCULOSIS COINFECTION; IN VITRO STUDY; MACROPHAGE; MALE; MIXED INFECTION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOUS PLEURISY; VIRUS REPLICATION;

ADULT; BLOTTING, WESTERN; COINFECTION; CYCLIN T; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDOLES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OXIMES; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; TRANSCRIPTIONAL ACTIVATION; TUBERCULOSIS; UGANDA; VIRUS REPLICATION;

EID: 84858026113     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0211     Document Type: Article

References (30)

1. Dye C, Lonnroth K, Jaramillo E, Williams BG, and Raviglione M: Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009; 87(9):683-691.
2. Toossi Z, Mayanja-Kizza H, Hirsch CS, et al.: Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001;123(2):233-238. (Pubitemid 32174774)
3. Kizza HM, Rodriguez B, Quinones-Mateu M, et al.: Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects. Clin Diagn Lab Immunol 2005;12(11):1298-1304. (Pubitemid 41626599)
4. Richter C, Perenboom R, Mtoni I, et al.: Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994;106(5):1471-1475.
5. Toossi Z, Johnson JL, Kanost RA, et al.: Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: Potential mechanisms of viral activation. J Acquir Immune Defic Syndr 2001;28(1):1-8. (Pubitemid 33104520)
6. Toossi Z, Mayanja-Kizza H, Baseke J, et al.: Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1- infected patients with active tuberculosis. Clin Exp Immunol 2005;142(2):327-332. (Pubitemid 41565249)
7. Fujinaga K, Cujec TP, Peng J, et al.: The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J Virol 1998;72(9):7154-7159. (Pubitemid 28377844)
8. Garber ME, Wei P, KewalRamani VN, et al.: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998;12(22):3512-3527. (Pubitemid 28553243)
9. Ali A, Ghosh A, Nathans RS, et al.: Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication. Chembiochem 2009;10(12):2072-2080.
10. Garriga J, Peng J, Parreno M, Price DH, Henderson EE, and Grana X: Upregulation of cyclin T1/CDK9 complexes during T cell activation. Oncogene 1998;17(24):3093-3102. (Pubitemid 29020805)
11. Wei P, Garber ME, Fang SM, Fischer WH, and Jones KA: A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998;92(4):451-462. (Pubitemid 28101109)
12. Ghose R, Liou LY, Herrmann CH, and Rice AP: Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J Virol 2001;75(23): 11336-11343. (Pubitemid 33063224)
13. Jadlowsky JK, Nojima M, Schulte A, Geyer M, Okamoto T, and Fujinaga K: Dominant negative mutant cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat. Retrovirology 2008;5:63.
14. Wang Y and Rice AP: Interleukin-10 inhibits HIV-1 LTRdirected gene expression in human macrophages through the induction of cyclin T1 proteolysis. Virology 2006;352(2):485-492. (Pubitemid 44216010)
15. Salerno D, Hasham MG, Marshall R, Garriga J, Tsygankov AY, and Grana X: Direct inhibition of CDK9 blocks HIV-1replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Gene 2007;405(1-2):65-78. (Pubitemid 350016664)
16. Biglione S, Byers SA, Price JP, et al.: Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Retrovirology 2007;4:47.
17. Hoessel R, Leclerc S, Endicott JA, et al.: Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999;1(1):60-67. (Pubitemid 129495012)
18. Heredia A, Davis C, Bamba D, et al.: Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS 2005;19(18):2087-2095. (Pubitemid 41668996)
19. Lawn SD, Pisell TL, Hirsch CS, Wu M, Butera ST, and Toossi Z: Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 2001;184(9):1127-1133. (Pubitemid 33010465)
20. Vanham G, Penne L, Allemeersch H, et al.: Modeling HIV transfer between dendritic cells and T cells: Importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS 2000;14(15):2299-2311.
21. Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, and Rich EA: Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993;177(5):1511-1516. (Pubitemid 23117144)
22. Mayanja-Kizza H, Wu M, Aung H, et al.: The interaction of monocyte chemoattractant protein-1 and tumour necrosis factor-alpha in Mycobacterium tuberculosis-induced HIV-1 replication at sites of active tuberculosis. Scand J Immunol 2009;69(6):516-520.
23. Schwander SK, Sada E, Torres M, et al.: T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis 1996;173(5):1267-1272. (Pubitemid 26251475)
24. Marshall RM, Salerno D, Garriga J, and Grana X: Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. J Immunol 2005;175(10):6402-6411. (Pubitemid 41598880)
25. Brasier AR: Expanding role of cyclin dependent kinases in cytokine inducible gene expression. Cell Cycle 2008;7(17):2661-2666.
26. Falco GD, Neri LM, Falco MD, et al.: Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines. Oncogene 2002;21(49):7464-7470.
27. Hou T, Ray S, and Brasier AR: The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 2007; 282(51):37091-37102.
28. Sundaravaradan V, Mehta R, Harris DT, Zack JA, and Ahmad N: Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells. Virology 2010;400(1):32-43.
29. Liou LY, Herrmann CH, and Rice AP: Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol 2002;76(21):10579-10587. (Pubitemid 35176174)
30. Rice AP and Herrmann CH: Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages. Curr HIV Res 2003;1(4):395-404.